Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q1 2023 Earnings

11MayConfirmed

Aug 22

Nov 22

Q4 2022

Q1 2023

-1.45

-1.26

-1.06

-0.87

Details

Expected EPS

-0.89

Actual EPS

-0.87

Surprise EPS

0.02

Surprise Percent

+2.25%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.87 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.